| How safe is cardiac imaging? | Radiation dose from cardiac computed tomography and nuclear cardiology. | Einstein A J (New York, US) |
| How safe is cardiac imaging? | Gadolinium risks. | Erbel R (Essen, DE) |
| How safe is cardiac imaging? | Ultrasound contrast agents - are they safe? | DeMaria A (San Diego, US) |
| How safe is cardiac imaging? | Implications of risk-benefit analyses in clinical practice. | Picano E (Pisa, IT) |
| The strengths of the imaging modalities in coronary artery disease - changing roles | The value of echocardiography. The viewpoint of a nuclear imaging expert. | Knuuti J M (Turku, FI) |
| The strengths of the imaging modalities in coronary artery disease - changing roles | The value of cardiovascular magnetic resonance. The viewpoint of an echocardiographer. | Nihoyannopoulos P (London, GB) |
| Cardiovascular imaging in multimodality environment | When cardiovascular imaging is appropriate. | Gibbons R (Rochester, US) |
| Cardiovascular imaging in multimodality environment | Detection of early disease. | Achenbach S (Erlangen, DE) |
| Cardiovascular imaging in multimodality environment | Multimodality imaging in coronary heart disease. | Bonow R (Chicago, US) |
| Cardiac imaging in 2020 | Combination of anatomic and perfusion assessment is the future. | Gibbons R (Rochester, US) |
| Cardiac imaging in 2020 | Cardiac ultrasound will do it all. | Marwick T H (Brisbane, AU) |
| Cardiac imaging in 2020 | Combined imaging techniques will be the standard. | Rademakers F E (Leuven, BE) |
| Cardiac computed tomography in coronary artery disease: when to use and when not to use | Cardiac computed tomography for risk stratification. | Weigold W G (Washington, US) |
| Cardiac computed tomography in coronary artery disease: when to use and when not to use | Suspected coronary artery disease. | Achenbach S (Erlangen, DE) |
| Imaging valve disease in 2008 | Resting echocardiography is all you need. | Thomas J D (Cleveland, US) |
| Imaging valve disease in 2008 | Functional assessment is mandatory. | Pierard L A (Liege, BE) |
| The year in clinical imaging | Echocardiography. | DeMaria A (San Diego, US) |
| The year in clinical imaging | Image fusion. | Reiber J H C (Leiden, NL) |
| Highlight Session | Imaging. | Pierard L A (Liege, BE) |
| The year in clinical imaging | Cardiovascular magnetic resonance. | F E Rademakers (Leuven, BE) |
| The strengths of the imaging modalities in coronary artery disease - changing roles | The value of computed tomography angiography. The viewpoint of an interventionalist. | P J De Feyter (Rotterdam, NL) |
| Cardiac computed tomography in coronary artery disease: when to use and when not to use | Bypass grafts and stents. | S Schroeder (Goeppingen, DE) |
| Imaging valve disease in 2008 | What is the value of magnetic resonance imaging and computed tomography? | J-L Vanoverschelde (Brussels, BE) |
| The strengths of the imaging modalities in coronary artery disease - changing roles | The value of nuclear imaging. The viewpoint of a cardiovascular magnetic resonance expert. | J Schwitter (Zurich, CH) |